Excerpts

In addition, within the phase I trial for SHR-1701, aggregated p-SMAD2 levels across all cancer subtypes (advanced solid tumors) showed a trend towards increased ORR with high baseline SMAD-2 levels [ 79 ].

While the Cox Hazard analysis reached statistical significance for re-excision as a protective factor for survival but not recurrence, there was a strong trend towards lower recurrence despite there being only 12 patients who did not undergo repeat surgery.

Finally, among cigarette smoking-related variables, a significant trend of increasing AL was observed with higher pack-years, longer smoking duration, earlier age of smoking initiation, and later age of smoking cessation.

In the multivariate analysis, a marginally significant association was observed between higher AL and increased lung cancer risk (per one AL unit: Hazard Ratio [HR] = 1.02, 95% Confidence Interval [CI]: 0.99, 1.04).

Tumor volume comparisons showed a trend toward smaller tumor volumes in the treatment group (median [range], 325 [200–700] mm 3 ) than in the control group (595 [250–800] mm 3 ), but the difference was not as great as in MC38 and was not significant ( Figure 4 e,f).

Statistical analysis revealed that the differences in RFS, DDFS, OS, and BCSS between the SLNB and ALND groups were highly significant.

On the other hand, the IMpassion031 trial comparing PD-L1 inhibitor atezolizumab to placebo given with nab-paclitaxel-EC followed by atezolizumab or placebo after surgery did show a significant improvement in pCR, but it demonstrated only a nonsignificant improvement in EFS with a strong trend for OS [ 94 , 116 ].

A systematic review of 12 retrospective clinical trials showed only a weak trend towards lower local recurrence rates after adjuvant postoperative radiotherapy compared to surgery alone [ 89 ]. 2.8.

In right-sided patients, T4 was also found to be a significant predictor of LNM (OR = 8.14, p = 0.019), with near significance in the general population ( Table 5 ). 3.4.

The incidence of HCC due to alcoholic liver disease has demonstrated an increasing trend from 1990 to 2019 [ 7 ].

Over the last few decades, there has been an increasing trend of adenocarcinoma compared to squamous cell carcinoma.

The distinct separation between the survival curves, coupled with the highly significant p -values, underscores the model’s reliability and potential predictive power for diverse, unseen patient populations.

An interesting trend in the high-ranking results was the presence of downregulated lipid droplet genes.

IMPT 1.04 ± 0.01, p < 0.001); however, no significant difference was apparent in the HI and CI of CTV.

In female rats, there was a positive trend in the incidence of renal tubule adenomas, which became significant in the 400 ppm 3-MCPD group [ 14 ].

Statistical significance was defined as p < 0.05, with p values between 0.05 and 0.1 considered marginally significant.

Other genetic abnormalities in AML cells may be significant in the treatment of patients, for example mutations in the FMS-like tyrosine kinase-3 ( FLT3 ) gene [ 6 ].

In the analysis of all-cause mortality for the different beta-lactam arm, newer publication years showed a trend favoring the combination of beta-lactam with aminoglycosides.

An ECOG performance status of 2 showed a trend towards a poorer PFS but was not statistically significant (HR: 1.89, 95% CI: 0.93–3.83, and p = 0.077).

Databases from developed countries like Japan, Switzerland, Italy, or Norway have also been recently bringing data showing an increasing trend in the incidence of NENs [ 12 , 13 ].

Still, Table 1 indicates a slight trend towards a higher chance of having a complete remission per increasing unit of the total doses to target volumes.

The patients of the RAMSES-01 group achieved significantly better LPFS (primary endpoint) and showed a strong trend towards improvement of motor function when compared to the control group [ 11 ].

First, the cumulative incidence of SPTM indicates an increasing trend from 1973 to 2014.

Without prospective evidence of benefit from additional adjuvant chemotherapy in these patients, we would suggest that surveillance protocols should be more individualized based on the highly significant association between pathological outcome and the incidence of TF.

These hubs are highly significant for network integrity; hence, their pharmacological inhibition stands higher chances for demolishing the AML network one-off.